Astute Medical is committed to improving patient outcomes through the identification and validation of novel biomarkers. Its immunoassay development and measurement methods help assess high-risk acute medical conditions and diseases. Innovative biomarkers. Smarter healthcare.
Avidity Biosciences is a privately held biotech company pioneering a new class of precision medicines – Antibody-siRNA Conjugates (ASC™) – which combine the strengths of monoclonal antibodies and siRNA-based therapeutics to overcome barriers to the delivery of siRNA and target genetic drivers of disease.
Avidity Biosciences signed Eli Lilly partnership agreement valued at $2.45B.
Sarah Boyle, President & CEO, Avidity Biosciences Inc.
Bloom is an in-home health tracker that makes it easy to achieve your optimal health and maintain it.
Bloom tests 15 different health variables from hydration levels and cortisol to specific vitamins and minerals, in just minutes, all from the comfort of home. The Bloom test card costs about $10. You urinate on the end of the card, then scan it with the Bloom app. Two minutes later you can see your levels for magnesium, potassium, calcium, iron, zinc, vitamin C, B7, B9, B12, hydration, PH, ketones, and cortisol and you get personalized food, supplements, and lifestyle recommendations to fix any issues with your health.
Bloom works with several of the best doctors, nutritionists, scientists, and medical experts to create a product that works to help you feel and perform at your best.
ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech. They leverage patented mathematical methods and algorithmic enhancements to enrich signal processing from the most popular life science instrumentation. They are using this to extract new information on biochemistry reactions and substantially increase the performance capabilities of today’s gold-standard biochemical assays at a very low cost.
Greg Gosch, President and CEO at ChromaCode, Inc.
Edico Genome created the world’s first bioinformatics processor designed to analyze next-generation sequencing data, DRAGEN™.
Investors include Qualcomm Ventures, Dell/EMC, and Microsoft
Alternative Medicine- One of California’s largest vertically-integrated cannabis companies with world-class capabilities including cultivation, extraction, manufacturing, brand sales, marketing, and distribution.
Indus Holdings, Inc. is politically astute, socially conscious, and dedicated to building a new industry by creating products that emphasize consumer safety while advancing changing perceptions on cannabis use.
Listed on the Canadian Stock Exchange as INDS.CN; OTC: INDXF
Savara Pharmaceuticals is a U.S.-based emerging pharmaceutical development company with an affiliate site in Denmark. The company is focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions.